Drug repositioning is a process of discovering new therapeutic uses for existing drugs. It is a cost-effective and time-efficient approach to drug discovery, as it eliminates the need to develop a new drug from scratch. The process involves analyzing existing drugs and their effects on the body, and then using this data to identify potential new uses for the drug. This can include treating different diseases, or even using the drug in combination with other drugs to create a more effective treatment. Drug repositioning has become increasingly popular in recent years, as it can help reduce the cost and time associated with drug discovery. It also has the potential to reduce the risk of side effects, as the drug has already been tested and approved for use. Companies in the drug repositioning market include GVK Biosciences, Novartis, Pfizer, and Johnson & Johnson. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
